Enradius, LLC – Trademark Portfolio

Entity Type: 16

Enradius, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 10 filings in this category. Currently, 9 trademarks are registered. Notable registered marks include MAP YOUR MARKETING, ADNETWORK YOUR PATH TO AREA DOMINANCE, OHIO AD NETWORK LOCAL ADS, LOCAL IMPACT, TEXAS AD NETWORK LOCAL ADS, LOCAL IMPACT, and LOCAL AD NETWORKS LOCAL ADS, LOCAL IMPACT. The owner is based in Baltimore, MD.

2920 O'Donnell Street

Baltimore, MD 21224

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Enradius, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (10 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Enradius, LLC have?

Enradius, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 9 registered, 1 cancelled.

What trademark classes does Enradius, LLC file in?

Enradius, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.

What are Enradius, LLC's most well-known trademarks?

Enradius, LLC's registered trademark portfolio includes well-known marks such as MAP YOUR MARKETING, ADNETWORK YOUR PATH TO AREA DOMINANCE, OHIO AD NETWORK LOCAL ADS, LOCAL IMPACT, TEXAS AD NETWORK LOCAL ADS, LOCAL IMPACT, and LOCAL AD NETWORKS LOCAL ADS, LOCAL IMPACT. These are among 9 currently registered trademarks in the portfolio.

What is Enradius, LLC's trademark registration success rate?

Enradius, LLC has a 90% trademark registration rate, with 9 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.